Vibe Pharmaceuticals LLC is an early-stage drug discovery company, spun out of the University of Pennsylvania, developing effective therapeutics for musculoskeletal disorders which lead to bone and muscle loss. The Vibe Pharmaceuticals technology is based on the well-established scientific observation that mechanical stimulation of responsive tissues, including bone and muscle, leads to increases in bone density and muscle mass. The Company team has developed a drug discovery platform for molecules that mediate bone and muscle mass increases and has identified specific proteins, which are being studied as active therapeutic candidates for osteoporosis, sarcopenia and related indications. Part of the UPStart incubator at the Univ. of Penn.
